Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 51 articles: HTML format Text format

Single Articles

January 2012
1. CHEN P , Pang X, Zhang Y, He Y, et al
   Effect of inhibition of the adrenomedullin gene on the growth and chemosensitivity of ovarian cancer cells.
   Oncol Rep. 2012 Jan 26. doi: 10.3892/or.2012.1655.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. HONG S , Li X, Zhao Y, Yang Q, et al
   53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway.
   Oncol Rep. 2012 Jan 18. doi: 10.3892/or.2012.1641.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. JAKUBOWSKA-MUCKA A , Sienko J, Zapala L, Wolny R, et al
   Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells.
   Oncol Rep. 2012 Jan 16. doi: 10.3892/or.2012.1639.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. WANG Y , Wang Y, Shen L, Pang Y, et al
   Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer.
   Oncol Rep. 2012 Jan 16. doi: 10.3892/or.2012.1638.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PENG DX , Luo M, Qiu LW, He YL, et al
   Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
   Oncol Rep. 2012 Jan 11. doi: 10.3892/or.2012.1625.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. WU B , Hu K, Li S, Zhu J, et al
   Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.
   Oncol Rep. 2012;27:101-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
7. BRUN JL , Cortez A, Lesieur B, Uzan S, et al
   Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
   Oncol Rep. 2011 Dec 22. doi: 10.3892/or.2011.1608.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SHENG XJ , Zhou YQ, Song QY, Zhou DM, et al
   Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.
   Oncol Rep. 2011 Dec 19. doi: 10.3892/or.2011.1596.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. ZHU J , Hua K, Sun H, Yu Y, et al
   Re-expression of estrogen receptor beta inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.
   Oncol Rep. 2011;26:1497-503.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
10. HOFSTETTER G , Berger A, Bauer EM, Schuster E, et al
    MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer.
    Oncol Rep. 2011 Nov 23. doi: 10.3892/or.2011.1560.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. LIU P , Gou M, Yi T, Xie C, et al
    Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Oncol Rep. 2011 Nov 11. doi: 10.3892/or.2011.1550.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ZHANG H , Zuo Z, Lu X, Wang L, et al
    MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
    Oncol Rep. 2011 Nov 8. doi: 10.3892/or.2011.1530.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
13. LORKOVA L , Pospisilova J, Lacheta J, Leahomschi S, et al
    Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: A potential biomarker identified by proteomics.
    Oncol Rep. 2011 Oct 21. doi: 10.3892/or.2011.1513.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. GUO Y , Fu P, Zhu H, Reed E, et al
    Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
    Oncol Rep. 2011 Oct 3. doi: 10.3892/or.2011.1483.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ZHOU X , Zhao F, Wang ZN, Song YX, et al
    Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
    Oncol Rep. 2011 Oct 3. doi: 10.3892/or.2011.1482.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. DEVOR EJ , Hovey AM, Goodheart MJ, Ramachandran S, et al
    microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Oncol Rep. 2011;26:995-1002.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
17. LEE JY , Shin JY, Kim HS, Heo JI, et al
    Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.
    Oncol Rep. 2011 Sep 14. doi: 10.3892/or.2011.1460.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HARUTA S , Furukawa N, Yoshizawa Y, Tsunemi T, et al
    Molecular genetics and epidemiology of epithelial ovarian cancer (Review).
    Oncol Rep. 2011 Sep 12. doi: 10.3892/or.2011.1456.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. YIN J , Yu C, Yang Z, He JL, et al
    Tetramethylpyrazine inhibits migration of SKOV3 human ovarian carcinoma cells and decreases the expression of interleukin-8 via the ERK1/2, p38 and AP-1 signaling pathways.
    Oncol Rep. 2011;26:671-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
20. QI X , Song X, Liu P, Yi T, et al
    Antitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancer.
    Oncol Rep. 2011 Jun 6. doi: 10.3892/or.2011.1337.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
21. CHO YR , Kim SH, Ko HY, Kim MD, et al
    Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70S6K-dependent VEGFR-2 expression.
    Oncol Rep. 2011 May 31. doi: 10.3892/or.2011.1335.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
22. SUN C , Yi T, Song X, Li S, et al
    Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.
    Oncol Rep. 2011 Apr 20. doi: 10.3892/or.2011.1275.
    PubMed     Text format     Related articles   
    
    
    
    
23. BUCKENDAHL AC , Budczies J, Fiehn O, Darb-Esfahani S, et al
    Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics.
    Oncol Rep. 2011;25:1005-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
24. ZHANG X , Wang X, Song X, Wei Z, et al
    Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas.
    Oncol Rep. 2011;25:353-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
25. KOMIYAMA S , Kurahashi T, Ishikawa M, Tanaka K, et al
    Expression of TGFss1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.
    Oncol Rep. 2011 Jan 18. doi: 10.3892/or.2011.1151.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WENDLER A , Keller D, Albrecht C, Peluso JJ, et al
    Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells.
    Oncol Rep. 2011;25:273-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. QIAN B , Katsaros D, Lu L, Canuto EM, et al
    IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics.
    Oncol Rep. 2011;25:203-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. GUO R , Wu Q, Liu F, Wang Y, et al
    Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Oncol Rep. 2011;25:141-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SEO HW , Rengaraj D, Choi JW, Park KJ, et al
    The expression profile of apoptosis-related genes in the chicken as a human epithelial ovarian cancer model.
    Oncol Rep. 2011;25:49-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. MATSUURA M , Suzuki T, Suzuki M, Tanaka R, et al
    Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.
    Oncol Rep. 2011;25:41-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
31. PENG P , Yan Y, Keng S
    Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.
    Oncol Rep. 2010 Dec 22. doi: 10.3892/or.2010.1119.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. JIAO JW , Wen F
    Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Oncol Rep. 2010 Dec 13. doi: 10.3892/or.2010.1107.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. OKUMA E , Ohishi Y, Oda Y, Aishima S, et al
    Cytoplasmic and stromal expression of laminin gamma 2 chain correlates with infiltrative invasion in ovarian mucinous neoplasms of gastro-intestinal type.
    Oncol Rep. 2010;24:1569-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
34. ZHOU L , Du L, Chen X, Li X, et al
    The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.
    Oncol Rep. 2010;24:941-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. WANG C , Zhou L, Li S, Wei J, et al
    C4orf7 contributes to ovarian cancer metastasis by promoting cancer cell migration and invasion.
    Oncol Rep. 2010;24:933-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. DOMANSKA K , Malander S, Staaf J, Karlsson A, et al
    Genetic profiles distinguish different types of hereditary ovarian cancer.
    Oncol Rep. 2010;24:885-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. YOON MS , Suh DS, Choi KU, Sol MY, et al
    High-throughput DNA hypermethylation profiling in different ovarian epithelial cancer subtypes using universal bead array.
    Oncol Rep. 2010;24:917-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
38. MYLONAS I
    Prognostic significance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas.
    Oncol Rep. 2010;24:385-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
39. TUMMALA R , Diegelman P, Fiuza SM, Batista de Carvalho LA, et al
    Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells.
    Oncol Rep. 2010;24:15-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
40. MINE T , Matsueda S, Gao H, Li Y, et al
    Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells.
    Oncol Rep. 2010;23:1537-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
41. GAO R , Shen Y, Cai J, Lei M, et al
    Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer.
    Oncol Rep. 2010;23:1293-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. LIU T , Cheng W, Lai D, Huang Y, et al
    Characterization of primary ovarian cancer cells in different culture systems.
    Oncol Rep. 2010;23:1277-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. MAMAT S , Ikeda J, Enomoto T, Ueda Y, et al
    Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma.
    Oncol Rep. 2010;23:1221-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KAJIHARA H , Yamada Y, Kanayama S, Furukawa N, et al
    Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).
    Oncol Rep. 2010;23:1193-203.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
45. LANGLAND GT , Yannone SM, Langland RA, Nakao A, et al
    Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities.
    Oncol Rep. 2010;23:1021-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. KUSUMOTO T , Kodama J, Seki N, Nakamura K, et al
    Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.
    Oncol Rep. 2010;23:917-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
47. LIU JJ , Lin B, Hao YY, Li FF, et al
    Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.
    Oncol Rep. 2010;23:833-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. YOSHIHARA C , Hamada K, Koyama Y
    Preparation of a novel adenovirus formulation with artificial envelope of multilayer polymer-coatings: Therapeutic effect on metastatic ovarian cancer.
    Oncol Rep. 2010;23:733-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ROOMI MW , Monterrey JC, Kalinovsky T, Rath M, et al
    In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
    Oncol Rep. 2010;23:605-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. PIZZAMIGLIO S , Cossa G, Gatti L, Beretta GL, et al
    Simultaneous confidence intervals to compare gene expression profiles using ABC transporter TaqMan microfluidic cards.
    Oncol Rep. 2010;23:853-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. ZHENG D , Li D, Lu X, Feng Z, et al
    Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.
    Oncol Rep. 2010;23:717-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: